- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2168-4804
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk Management in Drug-Device Combination Product Development ; volume:56 ; number:5 ; day:26 ; month:6 ; year:2022 ; pages:685-688 ; date:9.2022
Therapeutic innovation & regulatory science ; 56, Heft 5 (26.6.2022), 685-688, 9.2022
- Creator
-
Kumoluyi, Robin
Khanolkar, Amit
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-022-00425-w
- URN
-
urn:nbn:de:101:1-2022102122545819686950
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumoluyi, Robin
- Khanolkar, Amit
- SpringerLink (Online service)
Other Objects (12)
Challenges in the development of drug device combination products for biopharmaceuticals
Stability considerations for drug-device combination products-21 CFR part 4 update
"Green National Product": Good Intentions, Poor Device?
Direct Compaction Drug Product Process Modeling
Uncertain product risk, information acquisition, and product liability
Uncertain product risk, information acquisition, and product liability
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer
A Nontrivial Analysis of Patient Safety Risk from Parenteral Drug- and Medical Device-Borne Endotoxin
Too bad! Fixed dose combination antiretroviral drugs
Defining Patient Centric Pharmaceutical Drug Product Design
Cheminformatics in Natural Product‐based Drug Discovery
Challenges in the development of drug device combination products for biopharmaceuticals
Stability considerations for drug-device combination products-21 CFR part 4 update
"Green National Product": Good Intentions, Poor Device?
Direct Compaction Drug Product Process Modeling
Uncertain product risk, information acquisition, and product liability
Uncertain product risk, information acquisition, and product liability
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer
A Nontrivial Analysis of Patient Safety Risk from Parenteral Drug- and Medical Device-Borne Endotoxin
Too bad! Fixed dose combination antiretroviral drugs
Defining Patient Centric Pharmaceutical Drug Product Design
Cheminformatics in Natural Product‐based Drug Discovery
Challenges in the development of drug device combination products for biopharmaceuticals
Stability considerations for drug-device combination products-21 CFR part 4 update
"Green National Product": Good Intentions, Poor Device?
Direct Compaction Drug Product Process Modeling
Uncertain product risk, information acquisition, and product liability
Uncertain product risk, information acquisition, and product liability
Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear
Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer
A Nontrivial Analysis of Patient Safety Risk from Parenteral Drug- and Medical Device-Borne Endotoxin
Too bad! Fixed dose combination antiretroviral drugs
Defining Patient Centric Pharmaceutical Drug Product Design